Pharmacokinetics, pharmacodynamics, and tolerability of an aqueous formulation of rusfertide (PTG-300), a hepcidin mimetic, in healthy volunteers: A double-blind first-in-human study.
Saved in:
| Title: | Pharmacokinetics, pharmacodynamics, and tolerability of an aqueous formulation of rusfertide (PTG-300), a hepcidin mimetic, in healthy volunteers: A double-blind first-in-human study. |
|---|---|
| Authors: | Modi NB; Protagonist Therapeutics, Inc., Newark, California, USA., Shames R; Protagonist Therapeutics, Inc., Newark, California, USA., Lickliter JD; Nucleus Network, Melbourne, Victoria, Australia., Gupta S; Protagonist Therapeutics, Inc., Newark, California, USA. |
| Source: | European journal of haematology [Eur J Haematol] 2024 Sep; Vol. 113 (3), pp. 340-350. Date of Electronic Publication: 2024 May 24. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I |
| Journal Info: | Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
